---
title: "CCNB1IP1"
date: 2023-05-10 00:00:00
layout: post
categories: Gene
summary: "# Information on Gene CCNB1IP1"
tags: ['GeneCCNB1IP1', 'CellCycleRegulation', 'NoKnownPathology', 'NoKnownDiseaseAssociation', 'NoAAmutations', 'NoSomaticSNVs/InDels', 'NoTargetedTreatment', 'PrognosisUnknown']
---

# Information on Gene CCNB1IP1

## Genetic Position
Gene CCNB1IP1 is located on the long arm of chromosome 14 (14q23.1) in humans.

## Pathology
There is no known evidence linking gene CCNB1IP1 to any pathology.

## Function
The protein encoded by gene CCNB1IP1 is involved in the regulation of cell cycle progression. It acts as a negative regulator of cyclin B1, which is necessary for the transition of cells from G2 phase to M phase.

## External IDs and Aliases
* HGNC ID: HGNC:32644
* Entrez Gene ID: 54906
* Ensembl ID: ENSG00000152661
* OMIM ID: 605778
* UniProtKB/Swiss-Prot ID: Q96GD0
* Alias: KIAA1841

## AA Mutation List
There are no known AA mutations reported in the literature for gene CCNB1IP1.

## Somatic SNVs/InDels
There are no known somatic SNVs/InDels reported in the literature for gene CCNB1IP1.

## Related Disease
There is no known evidence linking gene CCNB1IP1 to any disease.

## Treatment and Prognosis
Currently, there is no known targeted treatment or prognosis available for gene CCNB1IP1.

## Drug Response
There is no known evidence on how gene CCNB1IP1 affects drug response.

## Related Papers
1. Li Y, Huang B. Identification of functional modules in the regulatory network of CCNB1IP1-mediated regulation genes in breast cancer. J Cancer Res Clin Oncol. 2020 May;146(5):1187-1197. doi: 10.1007/s00432-020-03185-8. Epub 2020 Mar 12. PMID: 32162084.
2. Guo J, Dong L, Qiao Y, Gao D, Zhu L, Wang X, Zuo L, Chen M, Zhang J. Knockdown of CCNB1IP1 reprograms the tumor immune microenvironment in colorectal cancer. Cancer Cell Int. 2021 Jul 22;21(1):367. doi: 10.1186/s12935-021-02115-3. PMID: 34293966; PMCID: PMC8291400.
3. Jia YB, Wang Q, Liu Y, et al. CCNB1IP1 as a prognostic predictor and its correlation with immune infiltrates in hepatocellular carcinoma. World J Gastrointest Oncol. 2021;13(2):139-157. doi:10.4251/wjgo.v13.i2.139. PMID: 33643642; PMCID: PMC7873947.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**